THE ABSORPTION AND METABOLISM OF ORAL OESTRADIOL, OESTRONE AND OESTRIOL

The absorption, metabolism and clearance of oestradiol, oestrone and oestriol from the peripheral circulation were investigated in five postmenopausal women after the oral administration of Hormonin (oestradiol 600 μg, oestrone 1400 μg, oestriol 270 μg) daily for five consecutive days. In addition the concentrations of plasma oestrone‐3‐sulphate, oestrone‐3‐glucuronide, LH and FSH were determined in the same plasma samples. The maximum concentrations of each steroid in peripheral plasma and the time intervals during which the peak occurred after ingestion of the last tablet were:—oestrone (750 to 2116 pmol/1, 0·5 to 6·0 hours), oestradiol (246 to 813 pmol/1, 1 to 8 hours), oestriol (173 to 241 pmol/1, 5 to 12 hours), oestrone‐3‐glucuronide (32·2 to 78·8 nmol/1, 0·5 to 3·0 hours) and oestrone‐3‐sulphate (21·9 to 39·0 nmol/1, 1 to 7 hours). The mean factorial increases in the concentration of each compound during the first 12 hours post‐treatment over the baseline values were:—oestrone (4·1); oestradiol (4·4); oestriol (1·7); oestrone‐3‐sulphate (2·6) and oestrone‐3‐glucuronide (8·1). After treatment, the concentration of plasma oestradiol remained significantly higher than the baseline values (p <0·025) for 24 hours and the values for each subject were within the normal range for premenopausal women. Moreover, there was a significant reduction (p < 0·025) in the level of circulating LH. It is concluded that the simultaneous administration of oestrone, oestradiol and oestriol, by mouth, to postmenopausal women is a good approach to maintaining an appropriate concentration of oestradiol in peripheral plasma.

[1]  J. Studd,et al.  HORMONAL PROFILES IN POSTMENOPAUSAL WOMEN AFTER THERAPY WITH SUBCUTANEOUS IMPLANTS , 1981, British journal of obstetrics and gynaecology.

[2]  W. Collins,et al.  Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins. , 1980, Journal of steroid biochemistry.

[3]  W. Collins,et al.  The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function. , 1979, Acta endocrinologica.

[4]  E. Johansson,et al.  PLASMA LEVELS OF OESTRONE, OESTRADIOL AND GONADOTROPHINS IN POSTMENOPAUSAL WOMEN AFTER ORAL AND VAGINAL ADMINISTRATION OF CONJUGATED EQUINE OESTROGENS (PREMARIN) , 1978, British journal of obstetrics and gynaecology.

[5]  S. Campbell,et al.  Clinical considerations in the management of the menopause: the endometrium. , 1978, Postgraduate medical journal.

[6]  K. Ryan,et al.  Vaginal absorption of estrone and 17beta-estradiol. , 1977, Fertility and sterility.

[7]  R. Doll,et al.  HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CARCINOMA , 1977, The Lancet.

[8]  H. Jacobs,et al.  PLASMA HORMONE PROFILES IN POST‐MENOPAUSAL WOMEN BEFORE AND DURING OESTROGEN THERAPY , 1977 .

[9]  W. Collins,et al.  Hormonal profiles after the menopause. , 1976, British medical journal.

[10]  D. Brock,et al.  SCREENING FOR NEURAL-TUBE DEFECTS , 1975, The Lancet.

[11]  S. Yen,et al.  Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women. , 1975, The Journal of clinical endocrinology and metabolism.

[12]  B. Macmahon,et al.  Estrogen profiles of Oriental and Caucasian women in Hawaii. , 1974, The New England journal of medicine.

[13]  D. Baird,et al.  Ovarian secretion rates of oestrogens, androgens and progesterone in normal women and in women with persistent ovarian follicles. , 1974, Acta endocrinologica.

[14]  Martin Pl,et al.  Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference. , 1972 .

[15]  W. Collins,et al.  Radioimmunoassay of oestrone and oestradiol in human plasma. , 1972, Acta endocrinologica.

[16]  P. Mozden,et al.  Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. , 1966, JAMA.

[17]  C. Migeon,et al.  Some aspects of the metabolism of 16-C14-estrone in normal individuals. , 1959, The Journal of clinical investigation.